Secondary Sclerosis Cholangitis Prospective
Recruiting
Observational Study
Secondary Sclerosis Cholangitis in Critically Ill Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 380 (estimated)
- Sponsor
- Medical University of Graz · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
SC-CIP is increasing in patients after critical illness. Pathogenesis is still largely unclear. Gut microbiome composition, gut permeability, bacterial translocation, inflammation and/or genetic variants contribute to the pathogenesis The aim of this project is to study gut microbiome composition, gut permeability, bacterial translocation, inflammation, bile acid composition and genetic polymorphi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant is willing and able to give informed consent for participation in the study OR "surrogate consent" by the institutional review board.
* Age above 18 years
* Mechanical ventilation or extracorporeal membrane oxygenation \>/= 5 days
Exclusion Criteria:
* Primary or…
Contacts
No contact information available.